Allergy Vaccine
SKU
MRR-436901065A74
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 1.28 billion
2030
USD 2.75 billion
2024
USD 1.43 billion
CAGR
11.51%
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-2030

[191 Pages Report] The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030.

Allergy Vaccine Market
To learn more about this report, request a free sample copy
An allergy vaccine, also known as allergen immunotherapy, is a form of treatment that aims to increase the patient's tolerance to allergens. It involves the controlled administration of specific allergens to decrease sensitivity and reduce allergic symptoms in the long term. The vaccines can be administered subcutaneously or sublingually and are tailored for various allergens, including pollens, dust mites, bee venom, and animal dander. The prevalence of allergic diseases globally, rising awareness of immunotherapy as a treatment option, and the growing acceptance of sublingual immunotherapy are primary driving factors. Technological advancements leading to more effective and convenient treatment methodologies also catalyze its need. Key factors hindering its adoption include high costs associated with allergy vaccines and treatment duration, potential side effects, and a lack of standardized allergen extracts. Additionally, the limited availability of allergy vaccines for a broad range of allergens poses a restraint. Challenges include stringent regulatory environments, the complexity of administering doses and ensuring patient compliance over the treatment period. Furthermore, there is a need for personalized treatment approaches and extensive research to enhance the efficacy of vaccines. The opportunities include expansion into emerging markets with growing healthcare sectors, advancements in molecular allergology, which could lead to the development of novel vaccines, and potential collaborations between research institutes and pharmaceutical companies to improve treatment outcomes.
Allergy Vaccine Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Allergy Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Allergy Vaccine Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló, Inc., Allergy Therapeutics PLC, Angany Inc., Astellas Pharma Inc., Biomay AG, DBV Technologies SA, Enesi Pharma Limited, Immunomic Therapeutics, Inc., Jubilant Pharma Limited, LETI Pharma, S.L.U., Merck & Co., Inc., Novartis AG, Sementis Ltd., Stallergenes Greer International AG, Sunstone by Anergis SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Allergy Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Allergy Type
    • Allergic Asthma
    • Cat Dander Allergy
    • Grass Pollen Hypersensitivity
    • Peanut Hypersensitivity
    • Seasonal Allergic Rhinitis
    • Tree Pollen Hypersensitivity
  • Vaccine Type
    • Cat Allergy Vaccine
    • House Dust Mite Allergy Vaccine
    • Injectable MPL Allergy Vaccine
    • Peanut Allergy Vaccine
    • Ragweed Allergy Immunotherapy Vaccine
  • Application
    • HIV
    • Oncology
    • Respiratory
  • End User
    • Homecare
    • Hospitals
    • Specialty Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Allergy Vaccine Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Vaccine Market?
  3. What are the technology trends and regulatory frameworks in the Allergy Vaccine Market?
  4. What is the market share of the leading vendors in the Allergy Vaccine Market?
  5. Which modes and strategic moves are suitable for entering the Allergy Vaccine Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageALLERGY VACCINE MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. ALLERGY VACCINE MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. ALLERGY VACCINE MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)ALLERGY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
    2. Allergy Vaccine Market, by RegionALLERGY VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)ALLERGY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL ALLERGY VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsALLERGY VACCINE MARKET DYNAMICS
      1. Drivers
        1. Increasing prevalence of allergies globally
        2. Increasing air pollution with industrialization
        3. Rising awareness among consumers about the allergies
      2. Restraints
        1. Limited allergy vaccine manufacturers
      3. Opportunities
        1. Research and development for the production of specific allergy vaccine
        2. Government and private sector initiatives in the production of vaccines
      4. Challenges
        1. Capital intensive in the production of allergy vaccines
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Allergy Vaccine Market, by Allergy Type
    1. IntroductionALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2030 (%)ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)
    2. Allergic AsthmaALLERGY VACCINE MARKET SIZE, BY ALLERGIC ASTHMA, BY , 2018-2030 (USD MILLION)
    3. Cat Dander AllergyALLERGY VACCINE MARKET SIZE, BY CAT DANDER ALLERGY, BY , 2018-2030 (USD MILLION)
    4. Grass Pollen HypersensitivityALLERGY VACCINE MARKET SIZE, BY GRASS POLLEN HYPERSENSITIVITY, BY , 2018-2030 (USD MILLION)
    5. Peanut HypersensitivityALLERGY VACCINE MARKET SIZE, BY PEANUT HYPERSENSITIVITY, BY , 2018-2030 (USD MILLION)
    6. Seasonal Allergic RhinitisALLERGY VACCINE MARKET SIZE, BY SEASONAL ALLERGIC RHINITIS, BY , 2018-2030 (USD MILLION)
    7. Tree Pollen HypersensitivityALLERGY VACCINE MARKET SIZE, BY TREE POLLEN HYPERSENSITIVITY, BY , 2018-2030 (USD MILLION)
  7. Allergy Vaccine Market, by Vaccine Type
    1. IntroductionALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
    2. Cat Allergy VaccineALLERGY VACCINE MARKET SIZE, BY CAT ALLERGY VACCINE, BY , 2018-2030 (USD MILLION)
    3. House Dust Mite Allergy VaccineALLERGY VACCINE MARKET SIZE, BY HOUSE DUST MITE ALLERGY VACCINE, BY , 2018-2030 (USD MILLION)
    4. Injectable MPL Allergy VaccineALLERGY VACCINE MARKET SIZE, BY INJECTABLE MPL ALLERGY VACCINE, BY , 2018-2030 (USD MILLION)
    5. Peanut Allergy VaccineALLERGY VACCINE MARKET SIZE, BY PEANUT ALLERGY VACCINE, BY , 2018-2030 (USD MILLION)
    6. Ragweed Allergy Immunotherapy VaccineALLERGY VACCINE MARKET SIZE, BY RAGWEED ALLERGY IMMUNOTHERAPY VACCINE, BY , 2018-2030 (USD MILLION)
  8. Allergy Vaccine Market, by Application
    1. IntroductionALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    2. HIVALLERGY VACCINE MARKET SIZE, BY HIV, BY , 2018-2030 (USD MILLION)
    3. OncologyALLERGY VACCINE MARKET SIZE, BY ONCOLOGY, BY , 2018-2030 (USD MILLION)
    4. RespiratoryALLERGY VACCINE MARKET SIZE, BY RESPIRATORY, BY , 2018-2030 (USD MILLION)
  9. Allergy Vaccine Market, by End User
    1. IntroductionALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)ALLERGY VACCINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    2. HomecareALLERGY VACCINE MARKET SIZE, BY HOMECARE, BY , 2018-2030 (USD MILLION)
    3. HospitalsALLERGY VACCINE MARKET SIZE, BY HOSPITALS, BY , 2018-2030 (USD MILLION)
    4. Specialty ClinicsALLERGY VACCINE MARKET SIZE, BY SPECIALTY CLINICS, BY , 2018-2030 (USD MILLION)
  10. Americas Allergy Vaccine Market
    1. Introduction
    2. AMERICAS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)AMERICAS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)AMERICAS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AMERICAS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)ARGENTINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)ARGENTINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ARGENTINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)BRAZIL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)BRAZIL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)BRAZIL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)CANADA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)CANADA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CANADA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)MEXICO ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)MEXICO ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MEXICO ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)UNITED STATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)UNITED STATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED STATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES ALLERGY VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  11. Asia-Pacific Allergy Vaccine Market
    1. Introduction
    2. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AUSTRALIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. China
    7. CHINA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)CHINA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)CHINA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CHINA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. India
    9. INDIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)INDIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)INDIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)INDONESIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)INDONESIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDONESIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)JAPAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)JAPAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)JAPAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)MALAYSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)MALAYSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MALAYSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)PHILIPPINES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SINGAPORE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SINGAPORE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SINGAPORE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH KOREA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)TAIWAN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)TAIWAN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TAIWAN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)THAILAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)THAILAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)THAILAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)VIETNAM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)VIETNAM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)VIETNAM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  12. Europe, Middle East & Africa Allergy Vaccine Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ALLERGY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)DENMARK ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)DENMARK ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)DENMARK ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)EGYPT ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)EGYPT ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EGYPT ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)FINLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)FINLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FINLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)FRANCE ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)FRANCE ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FRANCE ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)GERMANY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)GERMANY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)GERMANY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)ISRAEL ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)ISRAEL ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ISRAEL ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)ITALY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)ITALY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ITALY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NETHERLANDS ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)NIGERIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)NIGERIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NIGERIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)NORWAY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)NORWAY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NORWAY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)POLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)POLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)POLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)QATAR ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)QATAR ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)QATAR ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)RUSSIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)RUSSIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)RUSSIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SAUDI ARABIA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH AFRICA ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SPAIN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SPAIN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SPAIN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SWEDEN ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SWEDEN ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWEDEN ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWITZERLAND ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)TURKEY ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)TURKEY ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TURKEY ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY ALLERGY TYPE, 2018-2030 (USD MILLION)UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED KINGDOM ALLERGY VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  13. Competitive Landscape
    1. FPNV Positioning MatrixALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023ALLERGY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2023ALLERGY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
  14. Competitive Portfolio
    1. Key Company Profiles
      1. ALK-Abelló, Inc.
      2. Allergy Therapeutics PLC
      3. Angany Inc.
      4. Astellas Pharma Inc.
      5. Biomay AG
      6. DBV Technologies SA
      7. Enesi Pharma Limited
      8. Immunomic Therapeutics, Inc.
      9. Jubilant Pharma Limited
      10. LETI Pharma, S.L.U.
      11. Merck & Co., Inc.
      12. Novartis AG
      13. Sementis Ltd.
      14. Stallergenes Greer International AG
      15. Sunstone by Anergis SA
      16. Thermo Fisher Scientific Inc.
    2. Key Product Portfolio
  1. ALK-Abelló, Inc.
  2. Allergy Therapeutics PLC
  3. Angany Inc.
  4. Astellas Pharma Inc.
  5. Biomay AG
  6. DBV Technologies SA
  7. Enesi Pharma Limited
  8. Immunomic Therapeutics, Inc.
  9. Jubilant Pharma Limited
  10. LETI Pharma, S.L.U.
  11. Merck & Co., Inc.
  12. Novartis AG
  13. Sementis Ltd.
  14. Stallergenes Greer International AG
  15. Sunstone by Anergis SA
  16. Thermo Fisher Scientific Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Allergy Vaccine Market
The Global Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024.
The Global Allergy Vaccine Market to grow USD 2.75 billion by 2030, at a CAGR of 11.51%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.